产品编号 | bsk11024 |
英文名称 | Human VEGF ELISA Kit |
中文名称 | 人血管内皮生长因子酶联免疫试剂盒 |
别 名 | Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; Vegf; VEGFA; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGF A Precursor. |
Specific References (3) | bsk11024 has been referenced in 3 publications.
[IF=12.658] Tu Zewei. et al. Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy. J EXP CLIN CANC RES. 2023 Dec;42(1):1-19 ELISA ; Human.
[IF=6.244] Yang Chenbo. et al. Relationship Between PTEN and Angiogenesis of Esophageal Squamous Cell Carcinoma and the Underlying Mechanism. Front Oncol. 2021 Nov;0:4638 ELISA ; Human.
[IF=5.275] Tian-Wen Ni. et al. Alkaloid derivative ION-31a inhibits breast cancer metastasis and angiogenesis by targeting HSP90α. Bioorg Chem. 2021 Oct;115:105201 ELISA ; Mouse.
|
|
种 属 | Human |
线性范围 | 31.25 - 2,000 pg/mL |
应用范围 | S/P/CC |
检测限 | 7 pg/mL |
适用样品基质 | cell culture supernates, serum, and plasma. |
保存条件 | Store at 4°C for 12 months. |
注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
产品介绍 |
This gene product is a member of the PDGF/VEGF growth factor family. It is a mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis, endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Also, alternative translation initiation from non-AUG (CUG) and AUG start sites in some transcript variants, give rise to additional isoforms. [provided by RefSeq]. |
产品图片 | |
1、抗体溶解方法 | |
2、抗体修复方式 | |
3、常用试剂的配制 | |
4、免疫组化操作步骤 | |
5、免疫组化问题解答 | |
6、Western Blotting 操作步骤 | |
7、Western Blotting 问题解答 | |
8、关于肽链的设计 | |
9、多肽的溶解与保存 | |
10、酶标抗体效价测定程序 | |